$2.40
+0.04(1.48%)
Mkt Cap $110M
$1.39
$4.50
52-Week Range
At a Glance
AI-generated8-K
Microbot Medical Inc. announced that Emory Healthcare successfully completed robotic peripheral endovascular procedures using the LIBERTY Endovascular Robotic System, including the world's first robotic Prostatic Artery Embolization for BPH and robotic Y-90 radioembolization mapping for liver cancer. This demonstrates system adoption across multiple case types ahead of full market release.$110M
Market Cap
—
Revenue
-$12M
Net Income
Employees20
Fundamentals
How The Business Makes Money
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Industry Medical - Instruments & Supplies
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000883975
ISINUS59503A2042
CUSIP59503A204
Phone781 875 3605
Address25 Recreation Park Drive, Hingham, MA, 02043, US
SEC EDGAR